TrialPanorama/TrialPanorama-database huggingface dataset:
Study 34861036 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35997659 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 33951060 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32220372 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32220372 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34427066 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33215265 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study 33083489 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34034143 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35562804 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 32248552 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study 32248552 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32250470 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 32250470 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study 32250470 — Predictive Biomarker (PRD): HTR2C mRNA
Genes: HTR2C; HTR1C
Study 32250470 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 32250470 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 32250470 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 35325102 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32134713 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35798893 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 32756952 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 35786597 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32068914 — Predictive Biomarker (PRD): SLC5A1 mRNA
Genes: SLC5A1; NAGT; SGLT1
Study 32068914 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32068914 — Surrogate Endpoint (SUR): Blood pressure
Study 32068914 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34008203 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34318635 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 35279835 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 35279835 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34520608 — Predictive Biomarker (PRD): TRPM8 mRNA
Genes: TRPM8; LTRPC6; TRPP8
Study 34749739 — Safety Biomarker (SAF): Interleukin 1
Study 35440808 — Surrogate Endpoint (SUR): Blood pressure
Study 33632085 — Safety Biomarker (SAF): miR-18a
Genes: MIR18A
Study 33632085 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35075723 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 33183673 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 35011579 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 35839108 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33545615 — Predictive Biomarker (PRD): RARRES2 mRNA
Genes: RARRES2; TIG2
Study 35324465 — Predictive Biomarker (PRD): MTOR mRNA
Genes: MTOR; FRAP; FRAP1; FRAP2; RAFT1; RAPT1
Study 35324465 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35701155 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32577299 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 32768967 — Predictive Biomarker (PRD): PER1 mRNA
Genes: PER1; KIAA0482; PER; RIGUI
Study 32768967 — Predictive Biomarker (PRD): BMAL1 mRNA
Genes: BMAL1; ARNTL; BHLHE5; MOP3; PASD3
Study 33681731 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34080094 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34498507 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study 34454582 — Safety Biomarker (SAF): Hyaluronic acid
Study 35263150 — Predictive Biomarker (PRD): TNNT1 mRNA
Genes: TNNT1; TNT
Study 34524004 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34702654 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 32008920 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 32008920 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34476575 — Predictive Biomarker (PRD): HSP90B1 mRNA
Genes: HSP90B1; GRP94; TRA1
Study 34476575 — Predictive Biomarker (PRD): MAPKAPK3 mRNA
Genes: MAPKAPK3
Study 34476575 — Predictive Biomarker (PRD): PPP2R1A mRNA
Genes: PPP2R1A
Study 34476575 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 34476575 — Pharmacodynamic Biomarker (PDY): Retinoblastoma-associated protein
Genes: RB1
Study 34476575 — Predictive Biomarker (PRD): CFP mRNA
Genes: CFP; PFC
Study 34476575 — Predictive Biomarker (PRD): ZKSCAN5 mRNA
Genes: ZKSCAN5; KIAA1015; ZFP95
Study 34476575 — Predictive Biomarker (PRD): DDX50 mRNA
Genes: DDX50
Study 33138867 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35994868 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 32456250 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 32456250 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35585374 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33114186 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33114186 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33114186 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 33114186 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 32554219 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32411324 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33051793 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 33325645 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 33479775 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34262711 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34262711 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36191080 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33926423 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32661909 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35042918 — Surrogate Endpoint (SUR): Bone mineral density
Study 32223966 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study 36329553 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study 36329553 — Predictive Biomarker (PRD): PSEN1 mRNA
Genes: PSEN1; AD3; PS1; PSNL1
Study 33358235 — Surrogate Endpoint (SUR): Bone mineral density
Study 34295153 — Surrogate Endpoint (SUR): Blood pressure
Study 32470863 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 32470863 — Predictive Biomarker (PRD): TNNT1 mRNA
Genes: TNNT1; TNT
Study 32877981 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33030269 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 33030269 — Surrogate Endpoint (SUR): Blood pressure
Study 33888251 — Surrogate Endpoint (SUR): Blood pressure
Study 36346729 — Surrogate Endpoint (SUR): Bone mineral density
Study 32812824 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34995334 — Surrogate Endpoint (SUR): Blood pressure
Study 33771192 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 33771192 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 34183717 — Surrogate Endpoint (SUR): Blood pressure
Study 32471891 — Predictive Biomarker (PRD): C5AR1 mRNA
Genes: C5AR1; C5AR; C5R1
Study 32471891 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34170096 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35012927 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32064987 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 33447960 — Surrogate Endpoint (SUR): Blood pressure
Study 34733978 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study 32730183 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 35349976 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 34636463 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 34103473 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34103473 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35391541 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study 32036482 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36480560 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36480560 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study 36480560 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 36480560 — Predictive Biomarker (PRD): HMGCR mRNA
Genes: HMGCR
Study 36480560 — Predictive Biomarker (PRD): ABCA1 mRNA
Genes: ABCA1; ABC1; CERP
Study 34003226 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 34243738 — Surrogate Endpoint (SUR): Blood pressure
Study 33325757 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 33922576 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study 33922576 — Surrogate Endpoint (SUR): Blood pressure
Study 35399845 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32347137 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 32004568 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32255549 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32858228 — Surrogate Endpoint (SUR): Blood pressure
Study 32014055 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 37393402 — Monitoring Biomarker (MOI): HBV DNA
Study 86099028 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 32960464 — Predictive Biomarker (PRD): DBI mRNA
Genes: DBI
Study 32557974 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 35173164 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32036610 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 34275789 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34275789 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34955257 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 631563192 — Surrogate Endpoint (SUR): Blood pressure
Study 33761207 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 33761207 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 33761207 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 33761207 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 32247603 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32247603 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 33302879 — Predictive Biomarker (PRD): SLC6A7 mRNA
Genes: SLC6A7; PROT
Study 35772594 — Surrogate Endpoint (SUR): Serum sodium
Study 35772594 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 32080823 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 32080823 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32080823 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35027405 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36064592 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32776235 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 35333199 — Safety Biomarker (SAF): Hyaluronic acid
Study 32303794 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 32303794 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32303794 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 35012798 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35012798 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32567237 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 32569123 — Predictive Biomarker (PRD): CFB mRNA
Genes: CFB; BF; BFD
Study 32097092 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32097092 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 32097092 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 32097092 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34907536 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 34907536 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study 34907536 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 34907536 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34907536 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35698580 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 34413491 — Predictive Biomarker (PRD): ETV5 mRNA
Genes: ETV5; ERM
Study 32330373 — Surrogate Endpoint (SUR): Sperm parameters
Study 32330373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 32216032 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 32797324 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32820475 — Predictive Biomarker (PRD): AVPR2 mRNA
Genes: AVPR2; ADHR; DIR; DIR3; V2R
Study 33795322 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 33795322 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study 35288469 — Predictive Biomarker (PRD): CD69 mRNA
Genes: CD69; CLEC2C
Study 33516651 — Predictive Biomarker (PRD): RGN mRNA
Genes: RGN; SMP30
Study 34791679 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 34791679 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 35081255 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 34090870 — Predictive Biomarker (PRD): DNM1L mRNA
Genes: DNM1L; DLP1; DRP1
Study 34090870 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 34090870 — Predictive Biomarker (PRD): PINK1 mRNA
Genes: PINK1
Study 32111916 — Predictive Biomarker (PRD): NXF1 mRNA
Genes: NXF1; TAP
Study 34703265 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 34710538 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 32266494 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 33611623 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 35758895 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 35758895 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35758895 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study 34937681 — Surrogate Endpoint (SUR): Blood pressure
Study 34606578 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 33609277 — Safety Biomarker (SAF): IL-6 and IL-10
Study 36422222 — Surrogate Endpoint (SUR): Blood pressure
Study 34507573 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35864562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35864562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35452273 — Predictive Biomarker (PRD): KLRC1 mRNA
Genes: KLRC1; NKG2A
Study 33295083 — Predictive Biomarker (PRD): IL5RA mRNA
Genes: IL5RA; IL5R
Study 33295083 — Predictive Biomarker (PRD): ALOX15 mRNA
Genes: ALOX15; LOG15
Study 33295083 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 33295083 — Predictive Biomarker (PRD): CLC mRNA
Genes: CLC; LGALS10; LGALS10A
Study 33295083 — Predictive Biomarker (PRD): PDE4D mRNA
Genes: PDE4D; DPDE3
Study 34954967 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34010611 — Surrogate Endpoint (SUR): Blood pressure
Study 35902939 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 35222585 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35222585 — Safety Biomarker (SAF): IL-6 and IL-10
Study 35837133 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study 35051142 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 34488646 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34362344 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34362344 — Surrogate Endpoint (SUR): Pathological complete response
Study 32271710 — Safety Biomarker (SAF): Hyaluronic acid
Study 34556722 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 34667023 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34667023 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34667023 — Predictive Biomarker (PRD): Hormone receptor
Study 33642566 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34052785 — Surrogate Endpoint (SUR): Blood pressure
Study 33047449 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32497779 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33235112 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 36418455 — Surrogate Endpoint (SUR): Bone mineral density
Study 33122892 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 34516312 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 34516312 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33839205 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 33839205 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33055122 — Surrogate Endpoint (SUR): Blood pressure
Study 33730454 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35112416 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34043029 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34043029 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 35055603 — Surrogate Endpoint (SUR): Blood pressure
Study 35656988 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34581911 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 32024944 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 32024944 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study 34348355 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 32493447 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 35766564 — Surrogate Endpoint (SUR): Serum uric acid
Study 35261113 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 35261113 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32592578 — Predictive Biomarker (PRD): FANCC
Genes: FAC; FA3
Study 33314365 — Surrogate Endpoint (SUR): Serum creatinine
Study 33389313 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32652112 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 32652112 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 33217618 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33246482 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 34578981 — Predictive Biomarker (PRD): MAX mRNA
Genes: MAX; BHLHD4
Study 33413212 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35552287 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35552287 — Predictive Biomarker (PRD): BAG3 mRNA
Genes: BAG3; BIS
Study 34478863 — Predictive Biomarker (PRD): LTB4R mRNA
Genes: LTB4R; BLT; BLT1; BLTR; CMKRL1; GPR16; P2RY7
Study 33811051 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP